Surgical Outcomes of Rectal Gastrointestinal Stromal Tumor in the Era of Imatinib

被引：3
|
作者：
Emoto, Shin [1 ]
Akiyoshi, Takashi [1 ]
Mukai, Toshiki [1 ]
Yamaguchi, Tomohiro [1 ]
Nagasaki, Toshiya [1 ]
Konishi, Tsuyoshi [2 ]
Fukunaga, Yosuke [1 ]
机构：
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo, Japan
[2] Univ Texas MD Anderson Canc Ctr, Dept Colon & Rectal Surg, Houston, TX 77030 USA
来源：
JOURNAL OF GASTROINTESTINAL SURGERY | 2021年 / 25卷 / 11期
关键词：
Rectum; Gastrointestinal stromal tumor; Imatinib mesylate; Survival analysis; INTERSPHINCTERIC RESECTION; MANAGEMENT; GIST;
D O I：
10.1007/s11605-021-05017-x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2963 / 2965
页数：3
相关论文
共 50 条
  • [21] Treatment strategy of rectal gastrointestinal stromal tumor (GIST)
    Liu, Heli
    Yan, Zhongshu
    Liao, Guoqing
    Yin, Hongling
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (07) : 708 - 713
  • [22] Which is the best surgical approach for anorectal gastrointestinal stromal tumors in the post-imatinib era?
    Pucciarelli, S.
    Maretto, I.
    TECHNIQUES IN COLOPROCTOLOGY, 2013, 17 (05) : 477 - 478
  • [23] Clinicopathologic change of gastrointestinal stromal tumor after neoadjuvant imatinib followed by surgical resection
    Kang, Gil Ho
    Son, Myoung Won
    Han, Sun Wook
    Bae, Sang Ho
    Kim, Sung Yong
    Kim, Yong Jin
    Chung, Gui Ae
    Cho, Gyu Seok
    Lee, Moon Soo
    Park, Nae Kyeong
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2012, 82 (02): : 120 - 124
  • [24] Gastrointestinal stromal tumor (GIST) and imatinib
    Kubota T.
    International Journal of Clinical Oncology, 2006, 11 (3) : 184 - 189
  • [25] Effects of surgical management for gastrointestinal stromal tumor patients with liver metastasis on survival outcomes
    Liu, Lei
    Xia, Xiaomin
    Ju, Yiheng
    Zhang, Simeng
    Shi, Ning
    Du, Yongxing
    Zhan, Hanxiang
    Liu, Shanglong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [26] Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor
    Ser Yee Lee
    Brian K. P. Goh
    Eran Sadot
    Rahul Rajeev
    Vinod P. Balachandran
    Mithat Gönen
    T. Peter Kingham
    Peter J. Allen
    Michael I. D’Angelica
    William R. Jarnagin
    Daniel Coit
    Wai Keong Wong
    Hock Soo Ong
    Alexander Y. F. Chung
    Ronald P. DeMatteo
    Annals of Surgical Oncology, 2017, 24 : 202 - 210
  • [27] Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor
    Trent, Jonathan C.
    Dupart, Jheri
    Zhang, Wei
    CURRENT CANCER THERAPY REVIEWS, 2005, 1 (01) : 93 - 108
  • [28] Treatment of gastrointestinal stromal tumor after imatinib and sunitinib
    Montemurro, Michael
    Bauer, Sebastian
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (04) : 367 - 372
  • [29] Transvaginal resection of a rectal gastrointestinal stromal tumor
    Hara, Masayasu
    Takayama, Satoru
    Arakawa, Atsushi
    Sato, Mikinori
    Nagasaki, Takaya
    Takeyama, Hiromitsu
    SURGERY TODAY, 2012, 42 (09) : 909 - 912
  • [30] The effect of neoadjuvant Imatinib therapy on outcome and survival after rectal gastrointestinal stromal tumour
    Machlenkin, S.
    Pinsk, I.
    Tulchinsky, H.
    Ziv, Y.
    Sayfan, J.
    Duek, D.
    Rabau, M.
    Walfisch, S.
    COLORECTAL DISEASE, 2011, 13 (10) : 1110 - 1115
12345